Fresenius Medical Care (FMS) said Tuesday that it targets to reach mid-teens percentage in operating income margins by 2030 through its FME Reignite strategy.
The company said it has estimated 1.05 billion euros ($1.21 billion) in sustainable savings by the end of 2027 from its extended FME25 program, which it expects to help support its targeted operating income margins.
Fresenius' chief financial officer, Martin Fischer, said the company plans to allocate 800 million euros to 1 billion euros for capital expenditures annually for 2025 to 2030 to invest in its core business.
Additionally, Fresenius said it is starting a new share buyback program this year, with initial share repurchases of 1 billion euros over two years.
Shares of Fresenius were down more than 3% in recent premarket activity Tuesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。